News
Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.
The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.
The funds will be used to expand operations and attract new partners.
The company received an additional equity investment from OrbiMed.
About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.
The company offers computer vision technology that enables humanoids and robots to perceive the world in 3D similar to how humans use their eyes and depth perception.
The company will use the funds to expand its technology and operations across Medicaid, Medicare Advantage and ACA marketplace plans in the U.S.
Sanofi will implement BenchSci's Ascend across its global research organization.
Developed with Murdoch Children's Research Institute, the AI has shown 90% detection accuracy.
The deep multi-task learning AI analyses X-ray images of premature babies to identify intestinal perforation and its location.